Bill > AB1842

This bill requires group or individual health care service plans and health insurers that offer outpatient prescription drug benefits to provide coverage without prior authorization, step therapy, or utilization review for at least one medication approved by the U.S. Food and Drug Administration in each of four categories: medication for the reversal of opioid overdose, medication for the detoxification or maintenance treatment of a substance use disorder, long-acting buprenorphine products, and long-acting injectable naltrexone products. The bill also states that no reimbursement is required for local agencies or school districts since the only costs that may be incurred are from a new crime or infraction being created, eliminated, or having its penalty changed.

Budget and Finance, Health and Social Services

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202320240AB1842